[Heparin-induced thrombocytopenia type II: a clinically relevant problem?].
Böck
M
M
Institut für Transfusionsmedizin und Immunhämatologie, Universität Magdeburg, Deutschland.
Woitzyk
I
I
Jepsen
M S
MS
Molling
J
J
Welte
T
T
Leimkühler
K
K
Heim
M U
MU
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D015539:Platelet Activation / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects; D012307:Risk Factors; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*
D000925:Anticoagulants; D006493:Heparin